海峡药学
海峽藥學
해협약학
STRAIT PHARMACEUTICAL JOURNAL
2015年
5期
94-96
,共3页
灯盏细辛%灯盏花素%心脑血管疾病
燈盞細辛%燈盞花素%心腦血管疾病
등잔세신%등잔화소%심뇌혈관질병
Erigeron Breviscapus%Breviscapine%Cerebral Vascular Disease
目的:观察灯盏细辛和灯盏花素者在治疗心脑血管疾病的疗效比较。方法将病例分为灯盏细辛组和灯盏花素组,观察两组治疗心脑血管疾病时的住院天数、住院费用、疗效和症状治愈时间。结果两组总体有效率分别为92.5%和97.4%( P>0.05),但在药物经济学方面,灯盏细辛组(536.89+39.00元)明显低于灯盏花素组(705.59+53.55元);而在治疗心悸症状缓解时间方面,灯盏花素组优于灯盏细辛组。差异均有统计学意义( P<0.05)。结论在心脑血管疾病方面,灯盏细辛和灯盏花素在疗效、不良反应发生率和经济性相当。
目的:觀察燈盞細辛和燈盞花素者在治療心腦血管疾病的療效比較。方法將病例分為燈盞細辛組和燈盞花素組,觀察兩組治療心腦血管疾病時的住院天數、住院費用、療效和癥狀治愈時間。結果兩組總體有效率分彆為92.5%和97.4%( P>0.05),但在藥物經濟學方麵,燈盞細辛組(536.89+39.00元)明顯低于燈盞花素組(705.59+53.55元);而在治療心悸癥狀緩解時間方麵,燈盞花素組優于燈盞細辛組。差異均有統計學意義( P<0.05)。結論在心腦血管疾病方麵,燈盞細辛和燈盞花素在療效、不良反應髮生率和經濟性相噹。
목적:관찰등잔세신화등잔화소자재치료심뇌혈관질병적료효비교。방법장병례분위등잔세신조화등잔화소조,관찰량조치료심뇌혈관질병시적주원천수、주원비용、료효화증상치유시간。결과량조총체유효솔분별위92.5%화97.4%( P>0.05),단재약물경제학방면,등잔세신조(536.89+39.00원)명현저우등잔화소조(705.59+53.55원);이재치료심계증상완해시간방면,등잔화소조우우등잔세신조。차이균유통계학의의( P<0.05)。결론재심뇌혈관질병방면,등잔세신화등잔화소재료효、불량반응발생솔화경제성상당。
OBJECTIVE To observe the effect of Erigeron Breviscapus injection and breviscapine in the treat-ment of cardiovascular and cerebrovascular diseases.METHODS The cases were divided into erigeron breviscapus group and breviscapine group, hospitalization days, cost of hospitalization, treatment effect and cure time were ob-served and compared between two groups.RESULTS The overall effective rate of the two groups were 92.5%and 97.4%( P>0.05) ,but in the pharmacoeconomic aspects,erigeron breviscapus group (536.89+39.00) was signif-icantly lower than that of breviscapine group ( 705.59 +53.55 );and in the cure time of palpitation, breviscapine group was better than the erigeron breviscapus group.The differences were statistically significant ( P <0.05 ).CONCLUSION In the treatment of cardiovascular and cerebrovascular diseases,there are no siguificant differ-ence in the field of adverse reaction rate,economy and effectiveness between erigeron breviscapus and breviscapine.